Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma.

@article{Lee2006EnhancedAE,
  title={Enhanced antitumor effect of dendritic cell based immunotherapy after intratumoral injection of radionuclide Ho-166 against B16 melanoma.},
  author={Tae-Hyung Lee and Young-hun Cho and Jong Doo Lee and Woo Ick Yang and Jong Lan Shin and M Lee},
  journal={Immunology letters},
  year={2006},
  volume={106 1},
  pages={19-26}
}
Internal radiotherapy with the intratumoral injection of the beta-emitting radionuclide, Holmium (Ho)-166, into B16 melanoma resulted in a reduction in size and growth rate; however, complete remission was not always achieved. Therefore, additional dendritic cell (DC) therapy was investigated to determine whether it could improve therapeutic results… CONTINUE READING